---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-012172"
form_type: "8-K"
ticker: "VTAK"
cik: "0001716621"
company_name: "Catheter Precision, Inc."
filed_at: "2025-04-16T23:59:59+00:00"
generated_at: "2026-05-23T13:28:55.756145+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# Catheter Precision subsidiary seeks to buy heart-failure assets from Cardionomic

## Summary
- Subsidiary Cardionomix would acquire CPNS System assets for 1M restricted VTAK shares and $1.5M promissory note.
- Cardionomix is 82% owned by VTAK; CEO David Jenkins holds 5% directly and 7% via FatBoy Capital.
- Target closing in first half of Q2 2025; no signed agreement and no guarantee deal will close.
- Purchased assets are on 'AS IS' basis; subsidiary will need substantial future financing to develop them.
- Cardionomic, Inc. ceased operations; assets assigned for benefit of creditors to Seller LLC.

## SEC filing metadata
- accession: 0001437749-25-012172
- form_type: 8-K
- ticker: VTAK
- cik: 0001716621
- company_name: Catheter Precision, Inc.
- filed_at: 2025-04-16T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716621/000143774925012172/0001437749-25-012172-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716621/000143774925012172/vtak20250416_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-012172
- JSON: https://secwatch.observer/filing/0001437749-25-012172.json
- Plain text: https://secwatch.observer/filing/0001437749-25-012172.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.